12:00 AM
 | 
May 03, 1999
 |  BC Week In Review  |  Clinical News  |  Regulatory

Onyx regulatory update

ONXX received European Patent No. 689,447B1 claiming the use of adenoviruses modified to...

Read the full 41 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >